Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical rosiglitazone for atopic dermatitis
ChiCTR2500114709Phase 4Not yet recruiting
- Sponsor
- Wuhan University
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rosiglitazone in atopic dermatitis (AD), sponsored by Wuhan University. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
rosiglitazone
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on ChiCTR2500114709.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500114709.